Rev regulates translation of human immunodeficiency virus type 1 RNAs

Journal of General Virology

Volumn 90, Issue 5, 2009, Pages 1141-1147

  Groom, Harriet C T ^a   Anderson, Emma C ^b   Dangerfield, John A ^c   Lever, Andrew M L ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; REV PROTEIN; VIRUS RNA; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; RNA TRANSLATION; TRANSLATION REGULATION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN SYNTHESIS; UPREGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HIV-1; MUTATION; PROTEIN BIOSYNTHESIS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, MESSENGER; RNA, VIRAL; UP-REGULATION;

EID: 67449087214     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.007963-0     Document Type: Article

References (37)

1. Anderson, E. C. & Lever, A. M. L. (2006). Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol 80, 10478-10486.
2. Campbell, L. H., Borg, K. T., Haines, J. K., Moon, R. T., Schoenberg, D. R. & Arrigo, S. J. (1994). Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J Virol 68, 5433-5438.
3. Chaloin, L., Smagulova, F., Hariton-Gazal, E., Briant, L., Loyter, A. & Devaux, C. (2007). Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif. J Biomed Sci 14, 565-584.
4. Chang, D. D. & Sharp, P. A. (1989). Regulation by HIV Rev depends upon recognition of splice sites. Cell 59, 789-795.
5. D'Agostino, D. M., Felber, B. K., Harrison, J. E. & Pavlakis, G. N. (1992). The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol 12, 1375-1386.
6. Daly, T. J., Cook, K. S., Gray, G. S., Maione, T. E. & Rusche, J. R. (1989). Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342, 816-819.
7. Dangerfield, J. A., Hohenadl, C., Egerbacher, M., Kodajova, P., Salmons, B. & Gunzburg, W. H. (2005). HIV-1 Rev can specifically interact with MMTV RNA and upregulate gene expression. Gene 358, 17-30.
8. Emerman, M., Vazeux, R. & Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57, 1155-1165.
9. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C. & Wong-Staal, F. (1986). HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46, 807-817.
10. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci U S A 86, 1495-1499.
11. Gallego, J., Greatorex, J., Zhang, H., Yang, B., Arunachalam, S., Fang, J., Seamons, J., Lea, S., Pomerantz, R. J. & Lever, A. M. (2003). Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leader RNA. J Biol Chem 278, 40385-40391.
12. Greatorex, J., Gallego, J., Varani, G. & Lever, A. (2002). Structure and stability of wild-type and mutant RNA internal loops from the SL-1 domain of the HIV-1 packaging signal. J Mol Biol 322, 543-557.
13. Greatorex, J. S., Palmer, E. A., Pomerantz, R. J., Dangerfield, J. A. & Lever, A. M. L. (2006). Mutation of the Rev-binding loop in the human immunodeficiency virus 1 leader causes a replication defect characterized by altered RNA trafficking and packaging. J Gen Virol 87, 3039-3044.
14. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989). The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 63, 1265-1274.
15. Harrison, G. P. & Lever, A. M. (1992). The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 66, 4144-4153.
16. Harrison, G. P., Miele, G., Hunter, E. & Lever, A. M. (1998). Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J Virol 72, 5886-5896.
17. Heaphy, S., Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Karn, J., Lowe, A. D., Singh, M. & Skinner, M. A. (1990). HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60, 685-693.
18. Herbreteau, C. H., Weill, L., Décimo, D., Prévôt, D., Darlix, J. L., Sargueil, B. & Ohlmann, T. (2005). HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat Struct Mol Biol 12, 1001-1007.
19. Holland, S. M., Ahmad, N., Maitra, R. K., Wingfield, P. & Venkatesan, S. (1990). Human immunodeficiency virus Rev protein recognizes a target sequence in Rev-responsive element RNA within the context of RNA secondary structure. J Virol 64, 5966-5975.
20. Jin, Y. & Cowan, J. A. (2006). Targeted cleavage of HIV rev response element RNA by metallopeptide complexes. J Am Chem Soc 128, 410-411.
21. Kimura, T., Hashimoto, I., Nishikawa, M. & Fujisawa, J. (1996). A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal β-actin and viral protein expression. Biochimie 78, 1075-1080.
22. Lawrence, J. B., Cochrane, A. W., Johnson, C. V., Perkins, A. & Rosen, C. A. (1991). The HIV-1 Rev protein: A model system for coupled RNA transport and translation. New Biol 3, 1220-1232.
23. Legrain, P. & Rosbash, M. (1989). Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 57, 573-583.
24. Malim, M. H. & Cullen, B. R. (1993). Rev and the fate of pre-mRNA in the nucleus: Implications for the regulation of RNA processing in eukaryotes. Mol Cell Biol 13, 6180-6189.
25. Mann, D. A., Mikaélian, I., Zemmel, R. W., Green, S. M., Lowe, A. D., Kimura, T., Singh, M., Butler, P. J., Gait, M. J. & Karn, J. (1994). A molecular rheostat: Co-operative rev binding to stem I of the revresponse element modulates human immunodeficiency virus type-1 late gene expression. J Mol Biol 241, 193-207.
26. Mills, N. L., Daugherty, M. D., Frankel, A. D. & Guy, R. K. (2006). An α-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction. J Am Chem Soc 128, 3496-3497.
27. Moehle, K., Athanassiou, Z., Patora, K., Davidson, A., Varani, G. & Robinson, J. A. (2007). Design of β-hairpin peptidomimetics that inhibit binding of α-helical HIV-1 Rev protein to the Rev response element RNA. Angew Chem Int Ed Engl 46, 9101-9104.
28. Nakielny, S., Fischer, U., Michael, W. M. & Dreyfuss, G. (1997). RNA transport. Annu Rev Neurosci 20, 269-301.
29. Perales, C., Carrasco, L. & González, M. E. (2005). Regulation of HIV-1 env mRNA translation by Rev protein. Biochim Biophys Acta 1743, 169-175.
30. Purcell, D. F. & Martin, M. A. (1993). Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67, 6365-6378.
31. Ricci, E. P., Soto Rifo, R., Herbreteau, C. H., Décimo, D. & Ohlmann, T. (2008). Lentiviral RNAs can use different mechanisms for translation initiation. Biochem Soc Trans 36, 690-693.
32. Ruhl, M., Himmelspach, M., Bahr, G. M., Hammerschmid, F., Jaksche, H., Wolff, B., Aschauer, H., Farrington, G. K., Probst, H. & other authors (1993). Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol 123, 1309-1320.
33. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E. M. & Pavlakis, G. N. (1990). Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 64, 2519-2529.
34. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K. & Pavlakis, G. N. (1992). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 66, 7176-7182.
35. Sodroski, J., Goh, W. C., Rosen, C. A., Dayton, A., Terwilliger, E. & Haseltine, W. (1986). A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321, 412-417.
36. Ye, Y. & Li, B. (2006). 1′S-1′-acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport. J Gen Virol 87, 2047-2053.
37. Zhang, G., Zapp, M. L., Yan, G. & Green, M. R. (1996). Localization of HIV-1 RNA in mammalian nuclei. J Cell Biol 135, 9-18.